Connection

Manuel Ugarte-Gil to Humans

Back to Details
This is a "connection" page, showing publications Manuel Ugarte-Gil has written about Humans.
Manuel Ugarte-Gil
Connection Strength
0.094
Humans
  1. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up. Clin Rheumatol. 2021 Nov; 40(11):4725-4734.
    View in: PubMed
    Score: 0.008
  2. Rheumatology and psychiatry: allies in times of COVID-19. Clin Rheumatol. 2021 Aug; 40(8):3363-3367.
    View in: PubMed
    Score: 0.008
  3. Gorham-Stout Syndrome: A Phantom Bone Disease Treated With Bisphosphonates. J Clin Rheumatol. 2020 Aug; 26(5):e135-e136.
    View in: PubMed
    Score: 0.007
  4. Better Health-Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort. Arthritis Care Res (Hoboken). 2020 08; 72(8):1159-1162.
    View in: PubMed
    Score: 0.007
  5. Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort. J Rheumatol. 2019 10; 46(10):1299-1308.
    View in: PubMed
    Score: 0.006
  6. Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions. Expert Rev Clin Immunol. 2018 11; 14(11):915-931.
    View in: PubMed
    Score: 0.006
  7. Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al. Arthritis Rheumatol. 2018 12; 70(12):2098-2099.
    View in: PubMed
    Score: 0.006
  8. Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients. Clin Exp Rheumatol. 2018 Nov-Dec; 36(6):1008-1013.
    View in: PubMed
    Score: 0.006
  9. Remission or low disease activity as a target in systemic lupus erythematosus. Ann Rheum Dis. 2019 01; 78(1):e3.
    View in: PubMed
    Score: 0.006
  10. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus. 2018 May; 27(6):913-919.
    View in: PubMed
    Score: 0.006
  11. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL). Ann Rheum Dis. 2017 Dec; 76(12):2071-2074.
    View in: PubMed
    Score: 0.006
  12. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases. Rheumatology (Oxford). 2021 10 09; 60(SI):SI68-SI76.
    View in: PubMed
    Score: 0.002
  13. Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America. J Rheumatol. 2021 10; 48(10):1616-1622.
    View in: PubMed
    Score: 0.002
  14. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
    View in: PubMed
    Score: 0.002
  15. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America. J Clin Rheumatol. 2020 Sep; 26(6):215-217.
    View in: PubMed
    Score: 0.002
  16. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
    View in: PubMed
    Score: 0.002
  17. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
    View in: PubMed
    Score: 0.002
  18. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
    View in: PubMed
    Score: 0.002
  19. Genetics and genomics in Peru: Clinical and research perspective. Mol Genet Genomic Med. 2018 11; 6(6):873-886.
    View in: PubMed
    Score: 0.002
  20. First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR). Ann Rheum Dis. 2018 11; 77(11):1549-1557.
    View in: PubMed
    Score: 0.002
  21. Defining Quality of Rheumatologic Care: Peru. J Clin Rheumatol. 2017 Jun; 23(4):212-214.
    View in: PubMed
    Score: 0.001
  22. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017 08; 13(8):799-814.
    View in: PubMed
    Score: 0.001
  23. Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort. Semin Arthritis Rheum. 2017 10; 47(2):199-203.
    View in: PubMed
    Score: 0.001
  24. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients. Clin Rheumatol. 2017 Apr; 36(4):845-852.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.